- Home
- BORR vs AMLX Comparison
BORR vs AMLX Comparison
Compare BORR & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BORR
- AMLX
- Stock Information
- Founded
- BORR 2016
- AMLX 2014
- Country
- BORR Bermuda
- AMLX United States
- Employees
- BORR N/A
- AMLX N/A
- Industry
- BORR Oil & Gas Production
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- BORR Energy
- AMLX Health Care
- Exchange
- BORR Nasdaq
- AMLX Nasdaq
- Market Cap
- BORR 870.1M
- AMLX 749.9M
- IPO Year
- BORR 2019
- AMLX 2022
- Fundamental
- Price
- BORR $3.07
- AMLX $13.96
- Analyst Decision
- BORR Hold
- AMLX Strong Buy
- Analyst Count
- BORR 2
- AMLX 7
- Target Price
- BORR $3.25
- AMLX $16.86
- AVG Volume (30 Days)
- BORR 4.5M
- AMLX 1.8M
- Earning Date
- BORR 11-05-2025
- AMLX 11-06-2025
- Dividend Yield
- BORR 1.35%
- AMLX N/A
- EPS Growth
- BORR N/A
- AMLX N/A
- EPS
- BORR 0.20
- AMLX N/A
- Revenue
- BORR $989,000,000.00
- AMLX N/A
- Revenue This Year
- BORR $0.04
- AMLX N/A
- Revenue Next Year
- BORR N/A
- AMLX N/A
- P/E Ratio
- BORR $15.82
- AMLX N/A
- Revenue Growth
- BORR 7.73
- AMLX N/A
- 52 Week Low
- BORR $1.55
- AMLX $2.60
- 52 Week High
- BORR $4.47
- AMLX $16.96
- Technical
- Relative Strength Index (RSI)
- BORR 58.17
- AMLX 52.93
- Support Level
- BORR $2.91
- AMLX $13.96
- Resistance Level
- BORR $3.19
- AMLX $14.63
- Average True Range (ATR)
- BORR 0.15
- AMLX 0.88
- MACD
- BORR 0.04
- AMLX -0.24
- Stochastic Oscillator
- BORR 82.32
- AMLX 15.47
About BORR Borr Drilling Limited
Borr Drilling Ltd is a drilling contractor that owns and operates jack-up rigs of modern and high-specification designs providing drilling services to the oil and gas exploration and production industry. The company operates a fleet of around 16 jack-up drilling rigs. Geographically the activities are carried out through Norway.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.